Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p/METTL3/m(6)A/p21 pathway

Evidence suggests that metformin might be a potential candidate for breast cancer treatment. Yet, its relevant molecular mechanisms remain to be fully investigated. We found that metformin could suppress the N6-methyladenosine (m(6)A) level in breast cancer cells significantly. The latter has an ess...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Lin, Zhang, Xu, Huang, Yu-Zhou, Zhu, Yu-Lan, Xu, Ling-Yun, Li, Zhi, Dai, Xin-Yuan, Shi, Liang, Zhou, Xu-Jie, Wei, Ji-Fu, Ding, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801402/
https://www.ncbi.nlm.nih.gov/pubmed/33431790
http://dx.doi.org/10.1038/s41389-020-00290-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801402/
https://www.ncbi.nlm.nih.gov/pubmed/33431790
http://dx.doi.org/10.1038/s41389-020-00290-y

Ejemplares similares